Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
Saved in:
| Title: | Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials. |
|---|---|
| Authors: | Flórez-Grau G; Department of Immunology, Hospital Clinic i Provincial, Barcelona, Spain.; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Zubizarreta I; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Cabezón R; Department of Immunology, Hospital Clinic i Provincial, Barcelona, Spain.; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Villoslada P; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Benitez-Ribas D; Department of Immunology, Hospital Clinic i Provincial, Barcelona, Spain. |
| Source: | Frontiers in immunology [Front Immunol] 2018 May 31; Vol. 9, pp. 1169. Date of Electronic Publication: 2018 May 31 (Print Publication: 2018). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2018.01169 |
